TELA Bio (TELA) Tax Provisions (2025 - 2026)
TELA Bio (TELA) posted quarterly Tax Provisions of $60000.0 for Q1 2026, up 15.38% year-over-year from $52000.0 in Q1 2025, and up 5900.0% quarter-over-quarter from $1000.0 in Q4 2025.
TELA Bio (TELA) Tax Provisions (2025 - 2026) Analysis & Trends
TELA Bio's Tax Provisions history runs 2 years deep, the most recent figure standing at $60000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 15.38% year-over-year to $60000.0; the TTM figure through Mar 2026 stood at $94000.0 (changed N/A YoY), while the FY2025 annual figure was $86000.0, up 101.08% from the prior year.
- Tax Provisions for Q1 2026 stood at $60000.0, up from $1000.0 in the prior quarter.
- The five-year high for Tax Provisions was $60000.0 in Q1 2026, with the low at $1000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 596.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 288.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 155.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 278.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.40 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 119.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -185.98 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 72.50 Mn |
| 10 | TELA Bio | 35.91 Mn | 5.49 Mn | 13.94 Mn | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | 52,000.00 |